There are 1 companies tagged `lemna`; raised $156.4M from 27 investors

Biolex Therapeutics raised $156.4M from Dow Venture Capital, Johnson & Johnson Development Corporation, Clarus Ventures, Quaker BioVentures, Bioventures Investors, J.P. Morgan Securities Inc., InterSouth Partners, OrbiMed Advisors, Dogwood Equity, Investor Growth Capital, Mitsui Ventures, Investor Growth Capital, J.P. Morgan Securities Inc., Easton Capital, Quaker BioVentures, Polaris Venture Partners, InterSouth Partners, Mitsui Ventures, Johnson & Johnson Development Corporation, Dow Venture Capital, Polaris Venture Partners, InterSouth Partners, Quaker BioVentures, Johnson & Johnson Development Corporation, Mitsui Ventures, Kitty Hawk Capital, and Johnson & Johnson Development Corporation in 6 rounds.

SEC Biolex Gets $20M From Insiders, Sees Strong Data From Hepatitis C Drug Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING